Literature DB >> 15095547

Direct measurement of health care costs.

Mark W Smith1, Paul G Barnett.   

Abstract

Cost identification is fundamental to many economic analyses of health care. Health care costs are often derived from administrative databases. Unit costs may also be obtained from published studies. When these sources will not suffice (e.g., in evaluating interventions or programs), data may be gathered directly through observation and surveys. This article describes how to use direct measurement to estimate the cost of an intervention. The authors review the elements of cost determination, including study perspective, the range of elements to measure, and short-run versus long-run costs. They then discuss the advantages and drawbacks of alternative direct measurement methods such as time-and-motion studies, activity logs, and surveys of patients and managers. A parsimonious data collection effort is desirable, although study hypotheses and perspective should guide the endeavor. Special reference is made to data sources within the Department of Veterans Affairs (VA) health care system.

Entities:  

Mesh:

Year:  2003        PMID: 15095547     DOI: 10.1177/1077558703257001

Source DB:  PubMed          Journal:  Med Care Res Rev        ISSN: 1077-5587            Impact factor:   3.929


  22 in total

1.  Introduction of the Tools for Economic Analysis of Patient Management Interventions in Heart Failure Costing Tool: a user-friendly spreadsheet program to estimate costs of providing patient-centered interventions.

Authors:  Shelby D Reed; Yanhong Li; Shital Kamble; Daniel Polsky; Felicia L Graham; Margaret T Bowers; Gregory P Samsa; Sara Paul; Kevin A Schulman; David J Whellan; Barbara J Riegel
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-12-06

2.  Estimating the cost to U.S. health departments to conduct HIV surveillance.

Authors:  Ram K Shrestha; Stephanie L Sansom; Benjamin T Laffoon; Paul G Farnham; R Luke Shouse; Karen MacMaster; H Irene Hall
Journal:  Public Health Rep       Date:  2014 Nov-Dec       Impact factor: 2.792

3.  Cost Analysis and Performance Assessment of Partner Services for Human Immunodeficiency Virus and Sexually Transmitted Diseases, New York State, 2014.

Authors:  Britney L Johnson; James Tesoriero; Wenhui Feng; Feng Qian; Erika G Martin
Journal:  Health Serv Res       Date:  2017-08-11       Impact factor: 3.402

Review 4.  Costs of alcohol screening and brief intervention in medical settings: a review of the literature.

Authors:  Jeremy W Bray; Gary A Zarkin; Jesse M Hinde; Michael J Mills
Journal:  J Stud Alcohol Drugs       Date:  2012-11       Impact factor: 2.582

Review 5.  Asthma outcomes: healthcare utilization and costs.

Authors:  Lara J Akinbami; Sean D Sullivan; Jonathan D Campbell; Robert W Grundmeier; Tina V Hartert; Todd A Lee; Robert A Smith
Journal:  J Allergy Clin Immunol       Date:  2012-03       Impact factor: 10.793

6.  Health care expenditures attributable to smoking in military veterans.

Authors:  Paul G Barnett; Kim Hamlett-Berry; Hai-Yen Sung; Wendy Max
Journal:  Nicotine Tob Res       Date:  2014-09-19       Impact factor: 4.244

Review 7.  Emergent Challenges in Determining Costs for Economic Evaluations.

Authors:  Josephine C Jacobs; Paul G Barnett
Journal:  Pharmacoeconomics       Date:  2017-02       Impact factor: 4.981

8.  Translating research into practice: Protocol for a community-engaged, stepped wedge randomized trial to reduce disparities in breast cancer treatment through a regional patient navigation collaborative.

Authors:  Tracy A Battaglia; Karen M Freund; Jennifer S Haas; Nicole Casanova; Sharon Bak; Howard Cabral; Rachel A Freedman; Karen Burns White; Stephenie C Lemon
Journal:  Contemp Clin Trials       Date:  2020-04-17       Impact factor: 2.226

9.  Microcosting quantity data collection methods.

Authors:  Kevin D Frick
Journal:  Med Care       Date:  2009-07       Impact factor: 2.983

10.  The Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention: Study protocol of a multi-center randomized controlled trial.

Authors:  Rae Jean Proeschold-Bell; Donna M Evon; Christina Makarushka; John B Wong; Santanu K Datta; Jia Yao; Ashwin A Patkar; Paolo Mannelli; Terra Hodge; Susanna Naggie; Julius M Wilder; Michael W Fried; Donna Niedzwiecki; Andrew J Muir
Journal:  Contemp Clin Trials       Date:  2018-07-10       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.